Nuove formulazioni di levotiroxina nel trattamento dell’ipotiroidismo congenito
- 76 Downloads
Sommario
L’articolo riporta i risultati, sostanzialmente concordanti, degli unici due studi comparativi sul trattamento con due diverse formulazioni di levotiroxina (gocce e compresse) in neonati e lattanti ipotiroidei congeniti. La funzione tiroidea si normalizza molto rapidamente in tutti i casi trattati con entrambe le formulazioni, mentre la formulazione liquida sembra caratterizzarsi per una maggiore rapidità di assorbimento. Non si osservano, inoltre, a breve termine effetti negativi legati all’uso dell’etanolo come eccipiente nella formulazione liquida.
Parole chiave
Ipotiroidismo congenito Levotiroxina Formulazione liquida EtanoloNotes
Conflitto di interesse
Gli autori Alessandra Cassio e Beatrice Righi dichiarano di non avere conflitti di interesse.
Consenso informato
Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.
Studi sugli animali
Gli autori di questo articolo non hanno eseguito studi sugli animali.
Supplementary material
Bibliografia
- 1.Rastogi MV, LaFranchi SH (2010) Congenital hypothyroidism. Orphanet J Rare Dis 5:1–22 CrossRefGoogle Scholar
- 2.Cassio A, Corbetta C, Antonozzi I et al. (2013) The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance. J Endocrinol Invest 36:195–203 PubMedGoogle Scholar
- 3.Léger J, Olivieri A, Donaldson M et al. on behalf of ESPE-PES-SLEP-JSPE-APEG-ISPAE, and the Congenital Hypothyroidism Consensus Conference Group (2014) European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis and management of congenital hypothyroidism. J Clin Endocrinol Metab 99:363–384 CrossRefPubMedCentralPubMedGoogle Scholar
- 4.Von Heppe JH, Krude H, L’Allemand D et al. (2004) The use of L-T4 as liquid solution improves the praticability and individualized dosage in newborns and infants with congenital hypothyroidism. J Pediatr Endocrinol Metab 17:967–974 Google Scholar
- 5.Flores-Huerta S, Hernandez-Montes H, Argote RM, Villalpando S (1992) Effects of ethanol consumption during pregnancy and lactation on the outcome and postnatal growth of the offspring. Ann Nutr Metab 36:121–128 CrossRefPubMedGoogle Scholar
- 6.American Academy of Pediatrics (1984) Ethanol in liquid preparations intended for children. Paediatrics 73:405–407 Google Scholar
- 7.Yue CS, Scarsi C, Ducharme MP (2012) Pharmacokinetics and potential advantages of a new oral solution of Levothyroxine vs. other available dosage forms. Arzneimitttelforschung 62:631–636 CrossRefGoogle Scholar
- 8.Grussendorf M, Vaupel R, Wegscheider K (2004) Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients. Med Klin (Munich) 99:639–644 CrossRefGoogle Scholar
- 9.Touati G, Leger J, Toublanc JE et al. (1997) A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 156:94–98 CrossRefPubMedGoogle Scholar
- 10.Cassio A, Monti S, Rizzello A et al. (2013) Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J Pediatr 162:1264–1269 CrossRefPubMedGoogle Scholar
- 11.Peroni E, Vigone MC, Mora S et al. (2014) Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr 81:50–54 CrossRefPubMedGoogle Scholar